Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Atyeo

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Cell|September 5, 2024
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primatesEric M Mucker, Alec W Freyn, Sandra L Bixler, et al.
Viruses|November 27, 2021
Epidemiological and Immunological Features of Obesity and SARS-CoV-2Eric J Nilles, Sameed M Siddiqui, Stephanie Fischinger, et al.
Nature|June 23, 2021
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaquesJingyou Yu, Lisa H Tostanoski, Noe B Mercado, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Dynamics and significance of the antibody response to SARS-CoV-2 infectionAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
Science Immunology|October 9, 2020
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patientsAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
JAMA Network Open|December 22, 2020
Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 PandemicAndrea G Edlow, Jonathan Z Li, Ai-Ris Y Collier, et al.
Ebiomedicine|March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Nature Medicine|September 5, 2020
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamstersLisa H Tostanoski, Frank Wegmann, Amanda J Martinot, et al.
JAMA|March 11, 2021
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19Kathryn E Stephenson, Mathieu Le Gars, Jerald Sadoff, et al.
Science (New York, N.Y.)|May 22, 2020
DNA vaccine protection against SARS-CoV-2 in rhesus macaquesJingyou Yu, Lisa H Tostanoski, Lauren Peter, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Cell|September 5, 2024
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primatesEric M Mucker, Alec W Freyn, Sandra L Bixler, et al.
Viruses|November 27, 2021
Epidemiological and Immunological Features of Obesity and SARS-CoV-2Eric J Nilles, Sameed M Siddiqui, Stephanie Fischinger, et al.
Nature|June 23, 2021
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaquesJingyou Yu, Lisa H Tostanoski, Noe B Mercado, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Dynamics and significance of the antibody response to SARS-CoV-2 infectionAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
Science Immunology|October 9, 2020
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patientsAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
JAMA Network Open|December 22, 2020
Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 PandemicAndrea G Edlow, Jonathan Z Li, Ai-Ris Y Collier, et al.
Ebiomedicine|March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Nature Medicine|September 5, 2020
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamstersLisa H Tostanoski, Frank Wegmann, Amanda J Martinot, et al.
JAMA|March 11, 2021
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19Kathryn E Stephenson, Mathieu Le Gars, Jerald Sadoff, et al.
Science (New York, N.Y.)|May 22, 2020
DNA vaccine protection against SARS-CoV-2 in rhesus macaquesJingyou Yu, Lisa H Tostanoski, Lauren Peter, et al.
Pageof 8